WNV in Blood, Ramifications for Blood Donations (3) (Modified by Environmental Risk Analysis Program)

[WNV-L Moderator's Note: The following is a link to a transcript of
Hira Nakhasi's July 22-23 2004 briefing to the FDA Blood Products
advisory committee (BPAC). Nakhasi is director of FDA's Division of
Emerging and Transfusion Transmitted Diseases. During the briefing,
Nakhasi refers to an American Red Cross study indicating that WNV can
linger in the blood up to 49 days. ]

Nikashi's testimony is here with other WNV stuff at the beginning of
Friday morning. If you can't open this, go to the Dockets part of the
FDA website and find the most recent BPAC meeting.

  http://www.fda.gov/ohrms/dockets/ac/04/transcripts/2004-4057t2%20.DOC

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
WESTNILEVIRUS-L is an email discussion group for communication
and discussion about West Nile Virus, particularly regarding policy,
risk reduction and public education issues. It is moderated by
Dr. Lois Levitan, Program Leader of the Cornell University
Environmental Risk Analysis Program (ERAP).
To subscribe (or unsubscribe), send an email request with your name
and contact information to <envrisk@cornell.edu>.
To receive messages once a day in digest format, subscribers can
send an email to <listproc@cornell.edu> with message:
"set WESTNILEVIRUS-L mail digest-nomime".

Subscribers are encouraged to post to the group by sending
messages to <envrisk@cornell.edu>. Put "WNV Listserv" in
the subject line and send unformatted text, without attachments.
------------------------------------------------------------------------
---------------------
Received on Thu Aug 19 12:22:51 2004